Expert Elicitation for the Judgment of Prion Disease Risk Uncertainties
- 6 January 2011
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 74 (2-4) , 261-285
Abstract
There is a high level of uncertainty surrounding the potential for iatrogenic prion transmission through transplantation, medical instrument reuse, blood transfusion, and blood product use due to a lack of evidence-based research on this important risk issue. A group of specialists was enlisted to evaluate some of the knowledge gaps in this area using the “Classical Model,” a structured elicitation procedure for weighting and pooling expert judgment. The elicitation exercise was undertaken in March 2009 with 11 transmissible spongiform encephalopathy (TSE) experts who were first calibrated using a series of seed questions for which the answers are known; they were then asked to answer a number of target questions that are important for risk assessment purposes, but for which there remains high uncertainty at this time. The target questions focused on variant Creutzfeldt–Jakob disease (vCJD) prevalence, incubation times for vCJD, genetic susceptibility to prion disease, blood infectivity, prion reduction of blood and blood products, surgical instrument risks, and interspecies transmission of TSEs. The experts were also asked to perform pairwise risk rankings for 12 different potential routes of infection. Dura mater transplantation was seen as having the highest risk, while dental tissue grafts were viewed as presenting the lowest risk of iatrogenic transmission. The structured elicitation procedure provides a rational, auditable, and repeatable basis for obtaining useful information on prion disease risk issues, for which data are sparse.Keywords
This publication has 40 references indexed in Scilit:
- Multiorgan Detection and Characterization of Protease-Resistant Prion Protein in a Case of Variant CJD Examined in the United StatesPLOS ONE, 2010
- A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New GuineaPhilosophical Transactions of the Royal Society B: Biological Sciences, 2008
- Transfusion-transmitted infectionsJournal of Translational Medicine, 2007
- Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibilityJournal of The Royal Society Interface, 2005
- Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from bloodThe Lancet, 2004
- Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patientThe Lancet, 2004
- Prevalence of lymphoreticular prion protein accumulation in UK tissue samplesThe Journal of Pathology, 2004
- Factors determining the pattern of the variant Creutzfeldt-Jakob disease (vCJD) epidemic in the UKProceedings Of The Royal Society B-Biological Sciences, 2003
- Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samplesThe Lancet, 1999
- A new variant of Creutzfeldt-Jakob disease in the UKThe Lancet, 1996